Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹69 Cr.
Stock P/E
14.5
P/B
0.8
Current Price
₹25.7
Book Value
₹ 30.5
Face Value
10
52W High
₹47
52W Low
₹ 16.2
Dividend Yield
0%

Dhansa Labs Overview

Business

Dhansa Labs Ltd. operates in the Pesticides & Agrochemicals sector in India. The company is primarily involved in the manufacturing, formulation, and potentially marketing of various agrochemical products. These products typically include insecticides, herbicides, fungicides, plant growth regulators, and other crop protection chemicals designed to enhance agricultural productivity and protect crops from pests and diseases. Its core business model likely involves a combination of in-house manufacturing, contract manufacturing, and/or sourcing of active ingredients to produce finished formulations, which are then distributed to farmers, distributors, or other agricultural enterprises. The company generates revenue by selling these agrochemical products through its distribution network.

Revenue Mix

Specific revenue segmentation for Dhansa Labs Ltd. is not publicly available. However, based on its industry, potential segments could include:

Insecticides: Products targeting insect pests.

Herbicides: Products for weed control.

Fungicides: Products to prevent and control fungal diseases.

Plant Growth Regulators (PGRs) / Micronutrients: Products aimed at improving plant health and yield.

The revenue mix would typically depend on the product portfolio, regional agricultural practices, and seasonal demand patterns.

Industry

The Indian Pesticides & Agrochemicals industry is a significant global market, characterized by its reliance on agricultural output, monsoon patterns, and government policies. It comprises a mix of large multinational corporations, established domestic players, and numerous smaller and mid-sized companies. The industry is competitive, with players often vying on product efficacy, price, distribution reach, and regulatory approvals. Dhansa Labs Ltd., as a listed entity in this sector, is likely a mid-to-small sized player competing with a broader range of companies, from large players like UPL and PI Industries to regional manufacturers. Its positioning would depend on its specific product portfolio, geographic focus, and ability to innovate or offer cost-effective solutions.

MOAT

Without specific information, Dhansa Labs Ltd.'s durable competitive advantages are not immediately clear. Potential areas for a moat in the agrochemical sector include:

Regulatory Expertise & Approvals: Extensive product registrations and approvals can create high barriers to entry.

Distribution Network: A strong, extensive, and loyal distribution network, especially in rural areas, can be a significant advantage.

Formulation Capabilities: Expertise in developing effective and stable formulations from generic active ingredients.

Cost Leadership: Efficient manufacturing processes and supply chain management leading to lower production costs.

Brand Recognition: While less common for smaller players, a strong brand in specific product categories or regions can aid sales.

For a company of its likely size, a deep R&D pipeline for novel molecules is less probable; hence, moats are more likely to be built around execution, specific product niches, or regional strengths.

Growth Drivers

Key factors that could drive Dhansa Labs Ltd.'s growth over the next 3-5 years include:

Increased Agricultural Demand: Growing population and focus on food security in India drives demand for better crop protection.

Favorable Monsoon & Crop Cycles: Good monsoon seasons and higher crop acreage translate to increased agrochemical consumption.

New Product Launches: Introduction of new generic molecules, specialized formulations, or biological products that address emerging pest challenges or improve yield.

Expansion of Distribution Reach: Penetrating new geographies or strengthening existing networks to reach more farmers.

Government Support & Policies: Initiatives promoting agricultural growth, direct benefit transfers to farmers, and subsidies for inputs.

Export Opportunities: Tapping into international markets for agrochemical products.

Risks

Dhansa Labs Ltd. faces several business risks:

Monsoon Dependency: A significant portion of agricultural activity and, consequently, agrochemical demand, is highly reliant on unpredictable monsoon patterns.

Regulatory Changes: Stringent environmental regulations, product bans (e.g., certain pesticides), or complex registration processes can impact product portfolio and market access.

Raw Material Price Volatility: Fluctuations in the prices of key chemical intermediates and crude oil derivatives can impact production costs and margins.

Intense Competition: The Indian agrochemical market is competitive, leading to pricing pressures and potential market share erosion.

Pest Resistance: Pests developing resistance to existing chemicals necessitates continuous R&D and product innovation.

Counterfeit Products: The prevalence of fake agrochemicals can dilute market share, impact farmer trust, and harm the brand.

Environmental and Health Concerns: Increasing scrutiny over pesticide use can lead to public backlash or stricter usage norms.

Management & Ownership

As an Indian company, Dhansa Labs Ltd. is likely promoted and controlled by a founding family or a group of individuals who hold a significant stake. Details regarding the specific management team's experience, tenure, and strategic vision, as well as the exact ownership structure (e.g., promoter holding, institutional vs. public float), are not available in the provided information. Typically, promoter-led companies in this sector benefit from long-term vision but can also be subject to corporate governance risks if not managed professionally.

Outlook

The outlook for Dhansa Labs Ltd. presents a balanced view. On the positive side, the underlying demand for agrochemicals in India remains robust, driven by the need for food security, increasing farm mechanization, and the ongoing threat from pests and diseases. Favorable monsoons and supportive government policies could provide tailwinds for growth. The company's ability to innovate with new formulations, expand its distribution, and manage its cost base effectively will be crucial.

Conversely, the company operates in a highly cyclical industry dependent on weather patterns. Regulatory headwinds, intense competition from larger players, and volatility in raw material prices pose significant challenges. The ability to maintain product registrations, manage supply chain disruptions, and adapt to evolving agricultural practices and environmental concerns will be key determinants of its long-term success.

Dhansa Labs Share Price

Live · NSE · Inception: 1985
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

Dhansa Labs Quarterly Results

#(Fig in Cr.) Mar 2025 Jun 2025
Net Sales 31 28
Other Income 1 0
Total Income 31 28
Total Expenditure 28 25
Operating Profit 3 3
Interest 1 1
Depreciation 1 1
Exceptional Income / Expenses 0 0
Profit Before Tax 2 1
Provision for Tax 0 0
Profit After Tax 1 1
Adjustments 0 0
Profit After Adjustments 1 1
Adjusted Earnings Per Share 0.5 0.5

Dhansa Labs Profit & Loss

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 82 85 105 120 131 59
Other Income 1 1 3 2 2 1
Total Income 82 85 108 122 133 59
Total Expenditure 72 74 97 111 122 53
Operating Profit 10 11 11 11 12 6
Interest 4 3 2 2 3 2
Depreciation 3 3 3 3 3 2
Exceptional Income / Expenses 0 0 -0 -0 0 0
Profit Before Tax 3 5 6 5 6 3
Provision for Tax -7 1 0 -2 1 0
Profit After Tax 10 4 5 8 5 2
Adjustments 0 0 0 0 0 0
Profit After Adjustments 10 4 5 8 5 2
Adjusted Earnings Per Share 21.1 2 3 4.1 1.9 1

Dhansa Labs Balance Sheet

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds -8 19 19 32 76
Minority's Interest 0 0 0 0 0
Borrowings 30 14 13 16 11
Other Non-Current Liabilities -6 -5 -0 -2 -1
Total Current Liabilities 22 22 22 31 40
Total Liabilities 37 50 54 77 126
Fixed Assets 16 25 25 24 23
Other Non-Current Assets 1 0 0 4 16
Total Current Assets 20 24 28 48 87
Total Assets 37 50 54 77 126

Dhansa Labs Cash Flow

#(Fig in Cr.) Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 1 0 0 0
Cash Flow from Operating Activities 3 6 10 -13 -34
Cash Flow from Investing Activities -1 -1 -4 -5 -13
Cash Flow from Financing Activities -1 -5 -6 18 48
Net Cash Inflow / Outflow 0 -0 0 -0 0
Closing Cash & Cash Equivalent 1 0 0 0 1

Dhansa Labs Ratios

# Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 21.12 2.01 2.95 4.13 1.92
CEPS(Rs) 27.71 3.69 4.62 5.48 2.94
DPS(Rs) 0 0 0 0 0
Book NAV/Share(Rs) -16.07 10.74 4.87 11.24 26.4
Core EBITDA Margin(%) 11.92 12.23 7.49 7.54 7.33
EBIT Margin(%) 8.81 9.33 7.24 6.52 6.85
Pre Tax Margin(%) 3.78 5.71 5.25 4.51 4.6
PAT Margin (%) 12.65 4.23 5 6.41 3.64
Cash Profit Margin (%) 16.59 7.74 7.83 8.5 5.58
ROA(%) 27.64 8.18 10.12 11.85 4.72
ROE(%) 0 63.82 37.82 52.08 11.01
ROCE(%) 28.72 25.38 25.37 21.4 11.43
Receivable days 31.11 33.42 21.05 33.71 82.19
Inventory Days 38.99 42.03 48.53 57.1 70.19
Payable days 89.08 82.3 62.59 53.06 33.43
PER(x) 0 0 0 0 20.97
Price/Book(x) 0 0 0 0 1.52
Dividend Yield(%) 0 0 0 0 0
EV/Net Sales(x) 0.46 0.42 0.3 0.4 1.06
EV/Core EBITDA(x) 3.58 3.27 2.96 4.49 12.08
Net Sales Growth(%) 0 3.5 23.9 14.93 8.96
EBIT Growth(%) 0 9.62 -3.77 3.45 14.44
PAT Growth(%) 0 -65.42 46.59 47.36 -38.06
EPS Growth(%) 0 -90.47 46.58 39.95 -53.6
Debt/Equity(x) -4.19 0.95 1.63 1.41 0.62
Current Ratio(x) 0.92 1.13 1.29 1.56 2.19
Quick Ratio(x) 0.52 0.63 0.51 0.9 1.43
Interest Cover(x) 1.75 2.58 3.63 3.24 3.05
Total Debt/Mcap(x) 0 0 0 0 0.41

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR +9% +16% — —
Operating Profit CAGR +9% +3% — —
PAT CAGR -38% +8% — —
Share Price CAGR -39% — — —
ROE Average +11% +34% +33% +33%
ROCE Average +11% +19% +22% +22%

Dhansa Labs Shareholding Pattern

Latest · Jun 2026
100% held
Promoters 65.05 %
FII 0 %
DII (MF + Insurance) 0 %
Public (retail) 34.95 %
# Sep 2024 Mar 2025 Sep 2025 Mar 2026 Jun 2026
Promoter 69.970.1170.1570.1565.05
FII 1.460.01000
DII 4.112.341.960.720
Public 24.5327.5427.8929.1334.95
Others 00000
Total 100100100100100

Dhansa Labs Peer Comparison

Pesticides & Agrochemicals Edit Columns

Dhansa Labs Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Dhansa Labs Pros & Cons

Pros

  • Stock is trading at 0.8 times its book value
  • Company has a good return on equity (ROE) track record: 3 Years ROE 34%
  • Debtor days have improved from 53.06 to 33.43days.
  • Company has reduced debt.

Cons

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp